USFDA gives tentative nod to Zydus Cadila for Adapalene and Benzoyl Peroxide Gel

Adapalene and Benzoyl Peroxide combination is used to treat acne

70
USFDA
Picture: Pixabay

Last Updated on October 10, 2021 by The Health Master

Zydus Cadila has received tentative approval from the US Food and Drugs Administration (USFDA) to market Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%.

Adapalene and Benzoyl Peroxide combination is used to treat acne, the company notified via a statement.

It works by killing the bacteria that cause acne and by keeping the skin pores clean. The drug will be manufactured at the group’s Topical plant at Ahmedabad, it added.

The group now has 323 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04, it further said.

USFDA gives nod to Drug to treat Rare Autoimmune Disease

USFDA gives tentative nod to Lupin for generic Brexpiprazole tablets

Zydus Cadila gets USFDA nod for drug to treat Psoriasis

Zydus Cadila gets USFDA nod for Antidepressant drug

Zydus Cadila gets tentative nod from USFDA for Brexpiprazole tablets

USFDA to review use of Blood Disorder Therapy in children

Recommendation of restriction on import of IPA used by Pharma Industry

Licensing process to ASU drug manufacturers made Paperless

Dedicated chapter on Medical Devices should be included in Pharmacy Course:…

Generic medicines are cheaper as compared to branded and equally effective

USFDA gives nod to Drug to treat Rare Autoimmune Disease

Latest Notifications regarding Pharmaceuticals

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner